Insider Transactions in Q1 2023 at Dexcom Inc (DXCM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
5,442
-3.79%
|
$631,272
$116.4 P/Share
|
|
Mar 16
2023
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Open market or private sale
|
Direct |
2,303
-6.42%
|
$264,845
$115.0 P/Share
|
|
Mar 14
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$43,623
$111.86 P/Share
|
|
Mar 13
2023
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Open market or private sale
|
Direct |
6,229
-14.8%
|
$660,274
$106.27 P/Share
|
|
Mar 13
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Open market or private sale
|
Direct |
2,782
-4.82%
|
$294,892
$106.27 P/Share
|
|
Mar 13
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,010
-2.77%
|
$213,060
$106.27 P/Share
|
|
Mar 10
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,472
-3.67%
|
$718,392
$111.4 P/Share
|
|
Mar 10
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,115
-3.45%
|
$678,765
$111.4 P/Share
|
|
Mar 10
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,618
-2.89%
|
$1,067,598
$111.4 P/Share
|
|
Mar 10
2023
|
Donald Abbey EVP Global Business Services I |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,669
-1.8%
|
$1,295,259
$111.4 P/Share
|
|
Mar 10
2023
|
Andrew K Balo EVP Regulatory Strategy Clinic |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,670
-6.61%
|
$1,295,370
$111.4 P/Share
|
|
Mar 10
2023
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,812
-6.85%
|
$534,132
$111.4 P/Share
|
|
Mar 10
2023
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,204
-3.37%
|
$688,644
$111.4 P/Share
|
|
Mar 10
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,109
-1.78%
|
$1,788,099
$111.4 P/Share
|
|
Mar 10
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,845
-8.18%
|
$1,869,795
$111.4 P/Share
|
|
Mar 10
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,669
-2.57%
|
$1,295,259
$111.4 P/Share
|
|
Mar 10
2023
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,680
-3.7%
|
$630,480
$111.4 P/Share
|
|
Mar 10
2023
|
Kevin R Sayer President CEO and Chairman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,490
-3.35%
|
$4,161,390
$111.4 P/Share
|
|
Mar 08
2023
|
Teri L Lawver EVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,352
+50.0%
|
-
|
|
Mar 08
2023
|
Paul R Flynn EVP Global Revenue |
BUY
Grant, award, or other acquisition
|
Direct |
18,776
+20.13%
|
-
|
|
Mar 08
2023
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
BUY
Grant, award, or other acquisition
|
Direct |
21,769
+31.07%
|
-
|
|
Mar 08
2023
|
Kevin R Sayer President CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
54,422
+12.36%
|
-
|
|
Mar 08
2023
|
Barry J. Regan EVP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
18,776
+19.37%
|
-
|
|
Mar 08
2023
|
Michael Jon Brown EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,769
+23.65%
|
-
|
|
Mar 08
2023
|
Donald Abbey EVP Global Business Services I |
BUY
Grant, award, or other acquisition
|
Direct |
18,776
+7.87%
|
-
|
|
Mar 08
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,769
+20.06%
|
-
|
|
Mar 08
2023
|
Sadie Stern EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,769
+19.45%
|
-
|
|
Mar 08
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,885
+15.15%
|
-
|
|
Mar 08
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
BUY
Grant, award, or other acquisition
|
Direct |
18,776
+10.79%
|
-
|
|
Mar 08
2023
|
Girish Naganathan EVP Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,776
+27.21%
|
-
|
|
Mar 08
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,397
+7.65%
|
-
|
|
Mar 06
2023
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Open market or private sale
|
Direct |
226
-0.84%
|
$25,764
$114.4 P/Share
|
|
Mar 06
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,144
-3.08%
|
$2,068,416
$114.79 P/Share
|
|
Mar 01
2023
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
38,464
-5.29%
|
$4,231,040
$110.12 P/Share
|
|
Feb 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.3%
|
$45,732
$111.64 P/Share
|
|
Feb 22
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,400
-3.57%
|
$273,600
$114.54 P/Share
|
|
Jan 30
2023
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
56,844
-6.8%
|
$6,025,464
$106.36 P/Share
|
|
Jan 30
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,213
-3.59%
|
$234,578
$106.12 P/Share
|
|
Jan 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.3%
|
$44,084
$107.86 P/Share
|
|
Jan 20
2023
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
45,607
-9.66%
|
$4,788,735
$105.75 P/Share
|
|
Jan 18
2023
|
Kevin R Sayer President CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
90,720
+16.11%
|
-
|